COMPANY PRODUCT TYPE THERAPEUTIC AREA INDICATION PHASE STUDIES LOCATION PRODUCT
ADL Bionatur Solutions Splittera for diagnostics Diagnostic Others Splittera for diagnostics enhances the sensibility and accuracy of diagnostic systems. Already licensed in non-exclusivity for IVD systems to Biokit 5RTM Splittera for diagnostics
Therapeutic area: Others
ADM BIOPOLIS Microbiome Analysis Diagnostic Autoimmune & Inflammation
Dermatology
Digestive System
Metabolic / Endocrinology
Women´s health
Various 5RTM Worldwide Microbiome Analysis
Therapeutic area: Autoimmune & Inflammation
Dermatology
Digestive System
Metabolic / Endocrinology
Women´s health
Agrenvec Recombinant proteins, COVID-19 antigens Biomarkers / Diagnostic Infections COVID-19 antigens for immunoassay 2PreV SPAIN Recombinant proteins, COVID-19 antigens
Therapeutic area: Infections
ALGENEX (Alternative Gene Expression S.L.) ASFV diagnostic kit Diagnostic Infections African Swine Fever Virus 5RTM ASFV diagnostic kit
Therapeutic area: Infections
ALGENEX (Alternative Gene Expression S.L.) COVID19 diagnostic Biomarkers / Diagnostic Infections COVID19 diagnostic with several proteins 1R+D COVID19 diagnostic
Therapeutic area: Infections
AMADIX (Advanced marker discovery) PancreaDix Biomarkers / Diagnostic Cancer Innovative non-invasive blood-based test for early detection of pancreatic cancer and preneoplastic lesions 3CV Spain PancreaDix
Therapeutic area: Cancer
AMADIX (Advanced marker discovery) DiagnoLung Biomarkers / Diagnostic Cancer Innovative non-invasive blood-based test for early detection of lung cancer and as a tool for high risk screening population 3CV Spain DiagnoLung
Therapeutic area: Cancer
AMADIX (Advanced marker discovery) Colofast Biomarkers / Diagnostic Cancer Innovative blood-based test for colorectal cancer early detection 3CV Spain and Europe Colofast
Therapeutic area: Cancer
APTUS Biotech ChikTest Biomarkers / Diagnostic Infections Chikungunya virus diagnosis based on aptamers 1R+D Spain ChikTest
Therapeutic area: Infections
APTUS Biotech Apta-Leish Diagnostic Infections Leishmaniasis diagnosis based on aptamers 1R+D Spain Apta-Leish
Therapeutic area: Infections
APTUS Biotech AptaLung Biomarkers / Diagnostic Cancer Desarrollo de una aplicación diagnóstica de cáncer de Pulmón no microcítico (CPNM) precoz mediante biopsia líquida o aptahistoquímica. 1R+D AptaLung
Therapeutic area: Cancer
APTUS Biotech PREDIAPT Biomarkers / Diagnostic Cancer Desarrollo de dos aplicaciones pronósticas de respuesta a tratamiento con derivados del platino en cáncer de pulmón basado en biopsia líquida y aptahistoquímica. 1R+D PREDIAPT
Therapeutic area: Cancer
APTUS Biotech AptaDetect-HCV Diagnostic Infections Hepatitis C virus (HCV) diagnosis based on aptamers 1R+D Spain AptaDetect-HCV
Therapeutic area: Infections
Araclon Biotech ABtest-MASAS Service 40/42 Biomarkers Central Nervous System Alzheimer´s disease diagnostic service in the early stages by mass spectrometry. ISO9001 certified. 5RTM Europe ABtest-MASAS Service 40/42
Therapeutic area: Central Nervous System
Araclon Biotech ABtest-ELISA Service 40 / 42 Biomarkers Central Nervous System Alzheimer´s disease diagnostic service in the early stages. ISO9001 certified. 3CV Worldwide ABtest-ELISA Service 40 / 42
Therapeutic area: Central Nervous System
ATRYS HEALTH Personalized Medicine Patient monitoring equipment Cancer Expert system for breast and colon cancer patient management 3CV Spain Personalized Medicine
Therapeutic area: Cancer
ATRYS HEALTH Personalized Medicine Biomarkers Cancer Patient stratification in glioma 3CV Spain Personalized Medicine
Therapeutic area: Cancer
ATRYS HEALTH Personalized Medicine Biomarkers / Diagnostic Cancer Patient stratification for difuse large b-cell lymphoma therapy 3CV Spain Personalized Medicine
Therapeutic area: Cancer
ATRYS HEALTH mAb for diagnosis and prognosis of brain tumors and lesions Biomarkers / Diagnostic Cancer
Central Nervous System
Glioblastoma, neurodegenerative disease 1R+D Spain mAb for diagnosis and prognosis of brain tumors and lesions
Therapeutic area: Cancer
Central Nervous System
Biocross e4Risk Quantitative Biomarkers / Diagnostic Central Nervous System Determination of ApoE4 plasma quantification as a reliable predictor of pathological concentrations of Abeta peptide, Tau and phosphotau in cerebrospinal fluid of patients with clinical suspiction of Alzheimer´s Disease. 2PreV e4Risk Quantitative
Therapeutic area: Central Nervous System
Biocross AD Dementia test Biomarkers / Diagnostic Central Nervous System The AD Dementia test is a multiparametric test that combines the detection and quantification of up to 9 metabolites or proteins in a plasma sample. The input of these measurements into an algorithm provides an accurate diagnosis and classifies the patien 2PreV Europe AD Dementia test
Therapeutic area: Central Nervous System
Biocross Degenerative Dementia test Biomarkers / Diagnostic Central Nervous System The Degenerative Dementia test is based on the detection and quantification of up to 7 blood biomarkers that are specifically altered in patients affected by neurodegeneration due to FTD or AD. The DD test is conceived as a “screening” tool for use in cl 2PreV Europe Degenerative Dementia test
Therapeutic area: Central Nervous System
Biocross e4Risk Biomarkers / Diagnostic Central Nervous System e4Risk is a non-genetic, cost effective, and highly reliable test to evaluate the risk to develop late onset Alzheimer’s Disease. The test detects the presence of the ApoE4 protein in human blood plasma using high-throughput chemical chemistry analyzer. 5RTM Europe e4Risk
Therapeutic area: Central Nervous System
BIOHOPE Immmunobiogram TRANSPLANT Biomarkers / Diagnostic Kidney and Genitourinary system
Musculoskeletal Disorders
Immunobiogram test builds on the measurement of patient’s in-vitro T-cell-based immune response to individual immunosuppressive drugs following kidney transplantation. The test serves as a an aid to the management of immunosuppressive regimen being the te 4Reg. Spain, Denmark, Germany, Poland, USA Immmunobiogram TRANSPLANT
Therapeutic area: Kidney and Genitourinary system
Musculoskeletal Disorders
BIOHOPE Immunobiogram ARTHRITIS Biomarkers / Diagnostic Autoimmune & Inflammation Rheumatoid Arthritis: immunomodulation, immunosuppresion. IVD under development to help define the best immunosupressant combination possible for a certain patient to control the disease. 3CV Spain Immunobiogram ARTHRITIS
Therapeutic area: Autoimmune & Inflammation
Biokit S.A HemosIL Acustar ADAMTS13 Activity Assay Diagnostic Cardiovascular and circulatory systems Thrombotic thrombocytopenic purpura (TTP) 3CV Spain HemosIL Acustar ADAMTS13 Activity Assay
Therapeutic area: Cardiovascular and circulatory systems
BIOLAN HEALTH OSAXYL Diagnostic Digestive System Hypolactasia. Lactose intolerance 5RTM Spain OSAXYL
Therapeutic area: Digestive System
BIOLAN HEALTH BIOtest COVID_19 Diagnostic Infections COVID19 diagnosis 3CV Spain BIOtest COVID_19
Therapeutic area: Infections
Biomedal iVYCHEC GIP Stool Biomarkers / Diagnostic Autoimmune & Inflammation
Digestive System
Monitoring of the gluten free diet in celiac patients (professional use) 5RTM iVYCHEC GIP Stool
Therapeutic area: Autoimmune & Inflammation
Digestive System
Biomedal iVYCHEC GIP Urine Biomarkers / Diagnostic Autoimmune & Inflammation
Digestive System
Monitoring of the gluten free diet in celiac patients (professional use) 5RTM iVYCHEC GIP Urine
Therapeutic area: Autoimmune & Inflammation
Digestive System
Biomedal iVYLISA GIP Stool Others Autoimmune & Inflammation
Digestive System
Monitoring of the gluten free diet in celiac patients 5RTM Spain iVYLISA GIP Stool
Therapeutic area: Autoimmune & Inflammation
Digestive System
Biomedal GlutenDetect Stool Biomarkers / Diagnostic Autoimmune & Inflammation
Digestive System
Monitoring of the gluten free diet in celiac patients (patient use) 5RTM GlutenDetect Stool
Therapeutic area: Autoimmune & Inflammation
Digestive System
Biomedal GlutenDetect Urine Biomarkers / Diagnostic Autoimmune & Inflammation
Digestive System
Monitoring of the gluten free diet in celiac patients (patient use) 5RTM GlutenDetect Urine
Therapeutic area: Autoimmune & Inflammation
Digestive System
Biomedica Molecular Medicine SL Bio-miRCC Biomarkers / Diagnostic Cancer Bio-miRCC is a prognostic molecular profile for localized renal cancer patients which allows classify them in two risk groups (high and low risk), avoiding the intermediate risk group provided by the current classification systems. 3CV Spain, England Bio-miRCC
Therapeutic area: Cancer
BTI Biotechnology Institute New BTI Apnia Diagnostic Respiratory and Pulmonary system New Respiratory polygraphy device with 7 channels for the diagnosis of obstructive sleep apnea 5RTM New BTI Apnia
Therapeutic area: Respiratory and Pulmonary system
DIOMUNE SL SEPSISpredict Biomarkers / Diagnostic Cardiovascular and circulatory systems
Infections
Heart Infarction 2PreV Spain SEPSISpredict
Therapeutic area: Cardiovascular and circulatory systems
Infections
ENTRECHEM Microbioma analysis Biomarkers Others Development of biomarkers (Microbioma) 1R+D Microbioma analysis
Therapeutic area: Others
ENTRECHEM Bacterial biomarker of colon cancer Biomarkers Cancer Colon cancer 2PreV Bacterial biomarker of colon cancer
Therapeutic area: Cancer
FERRER EPIBREAST (FAB-118) Diagnostic Cancer Breast Cancer 1R+D Europe EPIBREAST (FAB-118)
Therapeutic area: Cancer
FERRER EPICUP (FAB-115) Diagnostic Cancer Cancer of Unkown Primary 5RTM Europe EPICUP (FAB-115)
Therapeutic area: Cancer
FUND. PROGRESO Y SALUD FISEVI-17010 Diagnostic Cancer Kit to predict and / or predict the response to a treatment with FGFR inhibitors. Lung cancer 1R+D FISEVI-17010
Therapeutic area: Cancer
FUND. PROGRESO Y SALUD FIMABIS-16005 Diagnostic Autoimmune & Inflammation Clavulanic acid allergy diagnosis 1R+D FIMABIS-16005
Therapeutic area: Autoimmune & Inflammation
FUND. PROGRESO Y SALUD FIMABIS-19016 Biomarkers Cancer Testicular cancer 1R+D FIMABIS-19016
Therapeutic area: Cancer
FUND. PROGRESO Y SALUD FIBICO Biomarkers / Diagnostic Cancer Cancer 1R+D FIBICO
Therapeutic area: Cancer
FUND. PROGRESO Y SALUD FISEVI-18012 Diagnostic Infections Methods for the prognosis of HIV-infected subjects. HIV 1R+D Europe FISEVI-18012
Therapeutic area: Infections
FUND. PROGRESO Y SALUD FIMABIS-14005 Biomarkers Cancer Breast cancer 2PreV FIMABIS-14005
Therapeutic area: Cancer
FUND. PROGRESO Y SALUD FIMABIS-20017 Diagnostic Metabolic / Endocrinology
Others
Classify pluripatological patients 3CV Spain FIMABIS-20017
Therapeutic area: Metabolic / Endocrinology
Others
FUND. PROGRESO Y SALUD FIMABIS-17007 Diagnostic Central Nervous System Diagnosis using DWI 1R+D FIMABIS-17007
Therapeutic area: Central Nervous System
FUND. PROGRESO Y SALUD FIMABIS-19013 Biomarkers Cancer Classify patients by the answer to anti-PD1 treatment 1R+D FIMABIS-19013
Therapeutic area: Cancer
FUND. PROGRESO Y SALUD FISEVI-18002 Diagnostic Others Methods for the diagnosis of atopic diseases sensitive to allergenic components of olea european pollen. Diagnosis of atopic diseases 1R+D Europe FISEVI-18002
Therapeutic area: Others
FUND. PROGRESO Y SALUD FIMABIS-18005 Biomarkers Autoimmune & Inflammation Treatment with IFNß in patients with multiple sclerosis 1R+D FIMABIS-18005
Therapeutic area: Autoimmune & Inflammation
FUND. PROGRESO Y SALUD GENYO-13001 / FIMABIS-13009 Biomarkers Autoimmune & Inflammation Lupus erythematosus / Allergy 2PreV Europe GENYO-13001 / FIMABIS-13009
Therapeutic area: Autoimmune & Inflammation
FUND. PROGRESO Y SALUD FIMABIS-18011 Biomarkers Autoimmune & Inflammation Rheumatoid arthritis 1R+D FIMABIS-18011
Therapeutic area: Autoimmune & Inflammation
FUND. PROGRESO Y SALUD FIBICO Biomarkers Autoimmune & Inflammation Rheumatoid arthritis 1R+D FIBICO
Therapeutic area: Autoimmune & Inflammation
FUND. PROGRESO Y SALUD FISEVI-62 Diagnotic Image Analisis tool Diagnostic/Imaging Digestive System Fibrosis / NASH (non-alcoholic steatohepatitis) 3CV Europe FISEVI-62 Diagnotic Image Analisis tool
Therapeutic area: Digestive System
FUND. PROGRESO Y SALUD FIBAO-17004 Diagnostic Women´s health Method for predicting gestational age of labor in a pregnant woman 1R+D FIBAO-17004
Therapeutic area: Women´s health
FUND. PROGRESO Y SALUD FIMABIS-17001 Biomarkers Metabolic / Endocrinology Bariatric surgeru in DM2 patients 1R+D FIMABIS-17001
Therapeutic area: Metabolic / Endocrinology
FUND. PROGRESO Y SALUD GENYO-19002 Diagnostic Cardiovascular and circulatory systems Method of obtaining useful data to diagnose hereditary hemorrhagic telangiectasia. 1R+D GENYO-19002
Therapeutic area: Cardiovascular and circulatory systems
FUND. PROGRESO Y SALUD FIBICO Biomarkers Cardiovascular and circulatory systems Others 1R+D FIBICO
Therapeutic area: Cardiovascular and circulatory systems
FUND. PROGRESO Y SALUD FIBAO-16014 Diagnostic Others Predictive model of anemia in patients treated with Ribavirin and Direct Action Antivirals 1R+D FIBAO-16014
Therapeutic area: Others
FUND. PROGRESO Y SALUD GENYO-19004 Diagnostic Autoimmune & Inflammation Systemic autoimmune diseases diagnostic and/or prognostic method 1R+D GENYO-19004
Therapeutic area: Autoimmune & Inflammation
FUND. PROGRESO Y SALUD FIMABIS-17002 Diagnostic Autoimmune & Inflammation Cephalosporin allergy diagnosis 1R+D FIMABIS-17002
Therapeutic area: Autoimmune & Inflammation
FUND. PROGRESO Y SALUD FIMABIS-80 Multiple Sclerosis Diagnostic Kit Biomarkers Autoimmune & Inflammation
Central Nervous System
Multiple sclerosis 3CV FIMABIS-80 Multiple Sclerosis Diagnostic Kit
Therapeutic area: Autoimmune & Inflammation
Central Nervous System
FUND. PROGRESO Y SALUD FIBAO-18008 Diagnostic Cancer Method of obtaining useful data to predict overall survival and relapse-free survival in cancer 1R+D FIBAO-18008
Therapeutic area: Cancer
FUND. PROGRESO Y SALUD FIBAO-16001 Diagnostic Others Method of obtaining useful data for the screening and diagnosis of Osteoporosis 1R+D FIBAO-16001
Therapeutic area: Others
FUND. PROGRESO Y SALUD FISEVI-19011 Diagnostic Infections In vitro method for the diagnosis of a Pneumocystis jirovecii infection 1R+D Pneumocystis jirovecii infection FISEVI-19011
Therapeutic area: Infections
FUND. PROGRESO Y SALUD FISEVI-14024 Diagnostic/Imaging Ophthalmology and optometry Open retinoscopy couplable to a smartphone. Fundus pathologies 3CV FISEVI-14024
Therapeutic area: Ophthalmology and optometry
FUND. PROGRESO Y SALUD FIBAO-17011 Diagnostic Infections Evaluation of the degree of liver involvement in patients infected by the normal transaminase virus hepatitis b 1R+D FIBAO-17011
Therapeutic area: Infections
FUND. PROGRESO Y SALUD FIBAO-16004 Biomarkers Central Nervous System Use of proinflammatory cytokines as a diagnostic marker in Episodic Vestibular Syndrome 1R+D FIBAO-16004
Therapeutic area: Central Nervous System
FUND. PROGRESO Y SALUD CABIMER-13001 Trombosis risk biomarker Biomarkers Cardiovascular and circulatory systems Mesenchymal Stem Cells (MSCs) 1R+D CABIMER-13001 Trombosis risk biomarker
Therapeutic area: Cardiovascular and circulatory systems
FUND. PROGRESO Y SALUD FISEVI-14023 Diagnostic/Imaging Method for risk prediction of death or vasospasm after subarachnoid haemorrhage. Critical care; subarachnoid haemorrhage, emergencies; neurology 1R+D Europe FISEVI-14023
Therapeutic area:
FUND. PROGRESO Y SALUD FIMABIS-15003 Biomarkers Metabolic / Endocrinology Diabetes / metabolic diseases 1R+D FIMABIS-15003
Therapeutic area: Metabolic / Endocrinology
FUND. PROGRESO Y SALUD FISEVI-18016 Diagnostic Infections Method to predict or forecast the risk of infection from an individual exposed to the Hepatitis C virus 1R+D FISEVI-18016
Therapeutic area: Infections
FUND. PROGRESO Y SALUD FISEVI-19008 Diagnostic Infections Kit and method for the rapid detection of bacteria resistant to combinations of beta-lactam antibiotics with beta-lactamase inhibitors, and of extended-spectrum resistance to beta-lactams in clinical asylees. ESRI test. Rapid detection of bacteria resista 1R+D FISEVI-19008
Therapeutic area: Infections
FUNDACIÓN JIMÉNEZ DÍAZ (Instituto de Investigación Sanitaria) Kit for Diagnosis and Prognosis Biomarkers / Diagnostic Autoimmune & Inflammation
Cardiovascular and circulatory systems
Kidney and Genitourinary system
Chronic Kidney Disease (CKD) / Asthma and Allegy severity / Ischaemic stroke and blood pressure 1R+D Spain Kit for Diagnosis and Prognosis
Therapeutic area: Autoimmune & Inflammation
Cardiovascular and circulatory systems
Kidney and Genitourinary system
FUNDACIÓN JIMÉNEZ DÍAZ (Instituto de Investigación Sanitaria) New kit for detection and quantification of Sin a1 (Yellow mustard) Diagnostic Metabolic / Endocrinology Food Allergy 2PreV Spain New kit for detection and quantification of Sin a1 (Yellow mustard)
Therapeutic area: Metabolic / Endocrinology
Fundacion MEDINA In vitro tests for toxicity, safety, ADME and plasma efficacy Diagnostic/Imaging Others Cytotoxicity, Neurotoxicity, Mitochondrial Toxicity, Cardiotoxicity, ADME tox 5RTM Spain In vitro tests for toxicity, safety, ADME and plasma efficacy
Therapeutic area: Others
Fundacion MEDINA Biomarkers Platform Biomarkers / Diagnostic Cancer Lung Colon Breast Pancreas 3CV Spain Biomarkers Platform
Therapeutic area: Cancer
Fundacion MEDINA Metabolomics Biomarkers Identification Platform Biomarkers / Diagnostic Cancer
Infections
Metabolic / Endocrinology
Cancer Infectious Metabolism and Infectious Biomarkers 3CV Spain Metabolomics Biomarkers Identification Platform
Therapeutic area: Cancer
Infections
Metabolic / Endocrinology
GENOMICA NEDXA Diagnostic/Imaging Others
Women´s health
Point of Care instrument/ Lab on a Chip 1R+D Spain NEDXA
Therapeutic area: Others
Women´s health
IIS La Fe Method for predicting cardiotoxicity risk in cancer patients receiving anthracyclines chemotherapy Biomarkers / Diagnostic Cancer
Cardiovascular and circulatory systems
In vitro method for predicting cardiotoxicity risk in a cancer patient receiving, or susceptible to receive, anthracyclines chemotherapy 5 based on the determination of the expression levels of a combination of 10 circulating miRNAs 2PreV Method for predicting cardiotoxicity risk in cancer patients receiving anthracyclines chemotherapy
Therapeutic area: Cancer
Cardiovascular and circulatory systems
IIS La Fe Determination of autoantibodies in autoimmune patients Ro/SSA+ Biomarkers / Diagnostic Autoimmune & Inflammation Measurement in a piezoelectric resonator of the relationship between different variables of an interfacial process of molecular recognition antigen-antibody for the screening of samples of autoimmune patients. 1R+D Spain Determination of autoantibodies in autoimmune patients Ro/SSA+
Therapeutic area: Autoimmune & Inflammation
IIS La Fe Porous material for the detection of Candida albicans and method of diagnosis Diagnostic/Imaging Infections Porous material for the detection of Candida albicans and method of diagnosis 2PreV Spain Porous material for the detection of Candida albicans and method of diagnosis
Therapeutic area: Infections
IIS La Fe Method for predicting response to continuous positive air pressure treatment Diagnostic Respiratory and Pulmonary system Predictive method of response to treatment with continuous positive air pressure (CPAP) in patients with sleep apnea and resistant hypertension. 1R+D Spain Method for predicting response to continuous positive air pressure treatment
Therapeutic area: Respiratory and Pulmonary system
IMMUNOSTEP KIT ELISA COVID-19 Biomarkers / Diagnostic Infections Test de anticuerpos que detecta la inmunidad frente a Covid-19 con más del 98% de fiabilidad 4Reg. KIT ELISA COVID-19
Therapeutic area: Infections
IMMUNOSTEP ThromboStep Diagnostic Cardiovascular and circulatory systems Autoimmune Thrombocytopenia Diagnosis by flow cytometry 5RTM Europe ThromboStep
Therapeutic area: Cardiovascular and circulatory systems
IMMUNOSTEP Hemodilución (Bmplex) Diagnostic Blood and Lymphatic systems Detection of hemodilution in bone marrow samples 3CV Worldwide Hemodilución (Bmplex)
Therapeutic area: Blood and Lymphatic systems
IMMUNOSTEP Infiltration in CNS Diagnostic Cancer Detection of Leptomeningeal disease 4Reg. Worldwide Infiltration in CNS
Therapeutic area: Cancer
IMMUNOSTEP Disposable device for leukocyte separation Diagnostic Autoimmune & Inflammation
Blood and Lymphatic systems
Hematological malignancies 2PreV Spain Disposable device for leukocyte separation
Therapeutic area: Autoimmune & Inflammation
Blood and Lymphatic systems
Integromics Genomics Analysis for Personalized Medicine/Diagnosis Biomarkers / Diagnostic Others Diagnostics and Imaging / Screening 1R+D Genomics Analysis for Personalized Medicine/Diagnosis
Therapeutic area: Others
IRYCIS Biomarkers immunotherapy treatment Biomarkers / Diagnostic Autoimmune & Inflammation
Others
Biomarkers based on IgE profile for determining oral immunotherapy treatment response in children with cow’s milk protein allergy (with F. Hospital CI) 3CV Spain Biomarkers immunotherapy treatment
Therapeutic area: Autoimmune & Inflammation
Others
IRYCIS Noverl biomarkers of acute kidney injury based on miRNAs Biomarkers / Diagnostic Kidney and Genitourinary system The identified panel of miRNAs can detect acute kidney injury (AKI) development before serum creatinine increases 3CV Spain Noverl biomarkers of acute kidney injury based on miRNAs
Therapeutic area: Kidney and Genitourinary system
IRYCIS Biomarkers toidentify IFN-BETA drug response in multiple sclerosis Biomarkers / Diagnostic Autoimmune & Inflammation
Central Nervous System
New patented method to identify good responders to Interferon beta (INF-beta) therapy in multiple sclerosis before treatment initiation 5RTM Spain Biomarkers toidentify IFN-BETA drug response in multiple sclerosis
Therapeutic area: Autoimmune & Inflammation
Central Nervous System
IRYCIS miRNA 127 agents for use in the treatment of renal fibrosis Biomarkers / Diagnostic Kidney and Genitourinary system A method of prophylactically or therapeutically treating Chronic kidney disease (CKD) or of reducing the risk of CKD disease progression in a patient comprising expressing miR-127 in the renal cells 3CV Spain miRNA 127 agents for use in the treatment of renal fibrosis
Therapeutic area: Kidney and Genitourinary system
Leitat ELISA kit to detect biomarker levels (S100A7) Biomarkers / Diagnostic Autoimmune & Inflammation
Cancer
Diagnosis and prognosis of several cancers 2PreV Spain ELISA kit to detect biomarker levels (S100A7)
Therapeutic area: Autoimmune & Inflammation
Cancer
Leitat Tailored-made formulations with nanoencapsulated active compounds Others Autoimmune & Inflammation
Dermatology
Atopic dermatitis, psoriasis 1R+D Spain Tailored-made formulations with nanoencapsulated active compounds
Therapeutic area: Autoimmune & Inflammation
Dermatology
Leitat ELISA kit to detect biomarker levels (S100P) Biomarkers / Diagnostic Autoimmune & Inflammation
Cancer
Diagnosis and prognosis of Pancreatic cancer, colon cancer, others 2PreV Spain ELISA kit to detect biomarker levels (S100P)
Therapeutic area: Autoimmune & Inflammation
Cancer
Leitat Metabolic profile Biomarkers Infections Helicobacter pylori infection, oxidative stress 1R+D Spain Metabolic profile
Therapeutic area: Infections
Leitat ELISA kit to detect biomarker levels (S100A4) Biomarkers / Diagnostic Autoimmune & Inflammation
Cancer
Diagnosis and prognosis of Pancreatic cancer, colon cancer, others 2PreV Spain ELISA kit to detect biomarker levels (S100A4)
Therapeutic area: Autoimmune & Inflammation
Cancer
Leitat In vitro cellular model for diagnosis Biomarkers Infections Helicobacter pylori virulence 1R+D Spain In vitro cellular model for diagnosis
Therapeutic area: Infections
Leitat Ready-to-use transport kits for xenobiotic interaction studies Others Others To identify xenobiotic interactions for regulatory purposes 5RTM Europe Ready-to-use transport kits for xenobiotic interaction studies
Therapeutic area: Others
Leukos Biotech AML IVD Biomarkers / Diagnostic Blood and Lymphatic systems
Cancer
AML 3CV Spain AML IVD
Therapeutic area: Blood and Lymphatic systems
Cancer
Life Length Telomere Analysis Technology (TAT Test) Biomarkers Cancer
Cardiovascular and circulatory systems
Others
Age related diseases, Cancer, Cardiovascular, Degenerative diseases 5RTM Europe, US Telomere Analysis Technology (TAT Test)
Therapeutic area: Cancer
Cardiovascular and circulatory systems
Others
Merck / Sysmex Inostics Liquid Biopsy RAS Biomarker Testing Biomarkers / Diagnostic Cancer
Digestive System
Metastatic colorectal cancer 1R+D Spain Liquid Biopsy RAS Biomarker Testing
Therapeutic area: Cancer
Digestive System
Myriad Genetics myPlan™ Renal Cancer Biomarkers / Diagnostic Cancer Test Prognostics for renal cancer 3CV myPlan™ Renal Cancer
Therapeutic area: Cancer
Myriad Genetics myChoice™ HRD Biomarkers / Diagnostic Cancer Companion diagnostic test to identify metastatic breast cancer, ovarian and other tumor types that may be sensitive to iPAPR and/or platinum 3CV Worldwide myChoice™ HRD
Therapeutic area: Cancer
Myriad Genetics myRisk™ Diagnostic Cancer Test for all hereditary cancer syndromes 4Reg. España myRisk™
Therapeutic area: Cancer
Myriad Genetics myPath™ Melanoma Biomarkers / Diagnostic Cancer Genetic profile to test pathogenic status of Melanoma biopsy 3CV Worldwide myPath™ Melanoma
Therapeutic area: Cancer
Myriad Genetics Vectra® DA Biomarkers Autoimmune & Inflammation
Musculoskeletal Disorders
Multi-biomarker blood test validated to measure Rheumatoid Arthritis 5RTM Vectra® DA
Therapeutic area: Autoimmune & Inflammation
Musculoskeletal Disorders
Myriad Genetics tumor BRACAnalysis CDx™ Biomarkers / Diagnostic Cancer Companion diagnostic tumor testing for mutations in BRCA1/2 genes indicated for patients with ovarian cancer treated with IPARP 4Reg. España tumor BRACAnalysis CDx™
Therapeutic area: Cancer
Myriad Genetics myPlan™ Lung Cancer Diagnostic Cancer Lung Cancer prognostic test based on Cell Cycle Progression Genes 3CV Worldwide myPlan™ Lung Cancer
Therapeutic area: Cancer
Myriad Genetics EndoPredict® Biomarkers / Diagnostic Cancer Breast cancer patients ER postive and HER2 negative 4Reg. España EndoPredict®
Therapeutic area: Cancer
Myriad Genetics Prolaris® Biomarkers Cancer Genetic test for prostate cancer 4Reg. España Prolaris®
Therapeutic area: Cancer
NIMGENETICS ExoNIM Plus Epilepsia Diagnostic Genetic Diseases and Dysmorphic syndromes Abordaje global para el estudio de las distintas formas clínicas de la epilepsia que analiza 223 genes con relevancia clínica a partir de la secuenciación del exoma completo (ExoNIM®). La secuencia obtenida queda almacenada, lo que permite la aplicación 5RTM Spain ExoNIM Plus Epilepsia
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
NIMGENETICS KaryoNIM Leukemia Diagnostic Cancer Plataforma genómica diseñada por NIMGenetics para la identificación de biomarcadores en la leucemia linfática crónica (LLC), que combina la tecnología de array CGH y de SNParray. 1. El array CGH ha demostrado ser la tecnología más eficaz en este tipo de 5RTM Spain KaryoNIM Leukemia
Therapeutic area: Cancer
NIMGENETICS ExoNIM Trio Diagnostic Genetic Diseases and Dysmorphic syndromes Aproximación de ExoNIM® basada en la secuenciación de los 19.000 genes del paciente y, sus progenitories. La información genética de los progenitores, permite determinar en las variantes identificadas el patrón de herencia. Esta aproximación facilita la i 5RTM Spain ExoNIM Trio
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
NIMGENETICS TrisoNIM Excellence Diagnostic Genetic Diseases and Dysmorphic syndromes Test de ADN fetal en sangre materna, mediante secuenciación masiva de última generación (NGS, Next Generation Sequencing) y la aplicación del algoritmo NIFTY®. TrisoNIM® es el primer test de ADN fetal realizado íntegramente en España. TrisoNIM® Excellenc 5RTM Spain TrisoNIM Excellence
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
NIMGENETICS TromboNIM Diagnostic Cardiovascular and circulatory systems
Genetic Diseases and Dysmorphic syndromes
Estudio genético de la trombofilia hereditaria dirigido a la identificación de pacientes con un riesgo incrementado de desarrollar enfermedad tromboembólica. Analiza 24 variantes en 18 Genes asociadas a un incremento en el riesgo trombótico. Incluye genes 5RTM Spain TromboNIM
Therapeutic area: Cardiovascular and circulatory systems
Genetic Diseases and Dysmorphic syndromes
NIMGENETICS ExoNIM Clínico Diagnostic Genetic Diseases and Dysmorphic syndromes Aproximación de ExoNIM® que se focaliza en el análisis de genes con fenotipo OMIM (Online Mendelian Inheritance in Man (OMIM). La secuencia completa queda almacenada, lo que permite la realización de diferentes análisis de forma secuencial. ExoNIM® Clíni 5RTM Spain ExoNIM Clínico
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
NIMGENETICS ExoNIM Personalizado Diagnostic Genetic Diseases and Dysmorphic syndromes Aproximación de ExoNIM® que permite el diseño de un panel de genes adaptados a las necesidades del especialista. Las principales ventajas de esta aproximación son: 1. Posibilidad de ampliación del análisis por aparición de nuevos síntomas, redefinición 5RTM Spain ExoNIM Personalizado
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
NIMGENETICS ExoNIM Dirigido Diagnostic Genetic Diseases and Dysmorphic syndromes Aproximación al análisis del exoma basada en la selección de genes asociados al fenotipo del paciente. Tras la secuenciación de los 19.000 genes del paciente, se analizan aquellos asociados al cuadro clínico. La secuencia completa queda almacenada, lo que 5RTM Spain ExoNIM Dirigido
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
OPERON Simple RSV Diagnostic Infections Lateral flow test for the detection of respiratory syncytial virus (RSV). 4Reg. Spain Simple RSV
Therapeutic area: Infections
OPERON Simple Flu Diagnostic Infections Lateral flow test for the detecion of Influeza A & B virus. 2PreV Spain Simple Flu
Therapeutic area: Infections
OPERON Simple Calprotectin Diagnostic Digestive System One-step immunochromatographic test for the qualitative detection of Calprotectin in human faeces 5RTM Spain Simple Calprotectin
Therapeutic area: Digestive System
OPERON CT Oligogen Biomarkers / Diagnostic Infections Molecular test for the detection of Chlamydia trachomatis 5RTM Spain CT Oligogen
Therapeutic area: Infections
OPERON Simple GDH Biomarkers / Diagnostic Digestive System
Infections
One-step immunochromatographic test for the qualitative detection of GDH from C. difficile in human faeces 5RTM Spain Simple GDH
Therapeutic area: Digestive System
Infections
OPERON MG Oligogen Biomarkers / Diagnostic Infections Test designed for the detection of Mycoplasma genitalium 5RTM Spain MG Oligogen
Therapeutic area: Infections
OPERON NG Oligogen Biomarkers / Diagnostic Infections Molecular Test for the detection of Neisseria goorrhoeae 5RTM Spain NG Oligogen
Therapeutic area: Infections
OPERON CT/NG/MG Oligogen Diagnostic Infections Molecular test for the simultaneous detection of Chlamydia trachomatis, Nisseria gonorrhoeae, and Mycobacterium genitalis. 5RTM Spain CT/NG/MG Oligogen
Therapeutic area: Infections
OPERON S. PneumoStrip Diagnostic Respiratory and Pulmonary system Molecular test for the serotyping of Streptococcus pneumoniae 4Reg. Spain S. PneumoStrip
Therapeutic area: Respiratory and Pulmonary system
OWL Metabolomics OWLfat Biomarkers / Diagnostic Digestive System Non-alcoholic fatty liver disease 3CV Europe OWLfat
Therapeutic area: Digestive System
OWL Metabolomics OWLfiber Biomarkers / Diagnostic Digestive System Liver Fibrosis 3CV Europe and America OWLfiber
Therapeutic area: Digestive System
OWL Metabolomics OWLNash Activity Diagnostic Digestive System NASH 1R+D Spain OWLNash Activity
Therapeutic area: Digestive System
Progenika Biopharma Promonitor - PoC Others Autoimmune & Inflammation Point of Care - Therapeutic drug monitoring 4Reg. Spain Promonitor - PoC
Therapeutic area: Autoimmune & Inflammation
Progenika Biopharma Promonitor - ELISA Others Autoimmune & Inflammation Therapeutic drug monitoring 1R+D Spain Promonitor - ELISA
Therapeutic area: Autoimmune & Inflammation
Progenika Biopharma Promonitor - PoC Others Autoimmune & Inflammation Point of Care - Therapeutic drug monitoring 1R+D Spain Promonitor - PoC
Therapeutic area: Autoimmune & Inflammation
Progenika Biopharma Promonitor - ELISA Others Autoimmune & Inflammation Therapeutic drug monitoring 4Reg. Spain Promonitor - ELISA
Therapeutic area: Autoimmune & Inflammation
PROMEGA BIOTECH IBÉRICA Microsatellite Instability Analysis CE-IVD Biomarkers / Diagnostic Cancer Characterize MSI Status by a Fluorescent Multiplex PCR-based method with CE/IVD label 5RTM Global Microsatellite Instability Analysis CE-IVD
Therapeutic area: Cancer
PROMEGA BIOTECH IBÉRICA Spectrum Compact CE System Diagnostic Cancer 4-capillary instrument labelled as CE to run MSI fragment analysis for cancer diagnosis 4Reg. Spectrum Compact CE System
Therapeutic area: Cancer
PROMEGA BIOTECH IBÉRICA Lumit SARS-CoV 2 Diagnostic Infections Immunoassay kit to detect SARS-CoV 2 4Reg. Lumit SARS-CoV 2
Therapeutic area: Infections
SECUGEN GENOTYPING Diagnostic/Imaging Ophthalmology and optometry Genetic risk for Age related Macular Degeneration 5RTM Worldwide GENOTYPING
Therapeutic area: Ophthalmology and optometry
SECUGEN NEXT GEN SEQUENCING Diagnostic/Imaging Central Nervous System
Genetic Diseases and Dysmorphic syndromes
Kidney and Genitourinary system
Genetic Diagnosis 5RTM Worldwide NEXT GEN SEQUENCING
Therapeutic area: Central Nervous System
Genetic Diseases and Dysmorphic syndromes
Kidney and Genitourinary system
SECUGEN DNA SEQUENCING Diagnostic/Imaging Genetic Diseases and Dysmorphic syndromes Genetic Diagnosis 5RTM Worldwide DNA SEQUENCING
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
SECUGEN Service for the detection and quantification of autoantibodies against CFH and CFI Biomarkers Autoimmune & Inflammation
Genetic Diseases and Dysmorphic syndromes
Complement system related disorders 5RTM Spain Service for the detection and quantification of autoantibodies against CFH and CFI
Therapeutic area: Autoimmune & Inflammation
Genetic Diseases and Dysmorphic syndromes
StemTek Therapeutics Treatment prediction system for advanced tumors Diagnostic Cancer Multiple cancers 1R+D Spain Treatment prediction system for advanced tumors
Therapeutic area: Cancer
StemTek Therapeutics POC system based on detection of circulating biomarkers Biomarkers / Diagnostic Cancer Colon cancer 1R+D Spain and Germany POC system based on detection of circulating biomarkers
Therapeutic area: Cancer
Thrombotargets Diagnosis sensor Diagnostic Central Nervous System Alzheimer Disease 2PreV Europe Diagnosis sensor
Therapeutic area: Central Nervous System
Vivia Biotech Personalized Medicine Test in Haematological Malignancies Biomarkers / Diagnostic Cancer Multiple Myeloma 3CV Europe Personalized Medicine Test in Haematological Malignancies
Therapeutic area: Cancer
Vivia Biotech Personalized Medicine Test in Haematological Malignancies Diagnostic Blood and Lymphatic systems
Cancer
Acute Myeloid Leukaemia 5RTM Europe Personalized Medicine Test in Haematological Malignancies
Therapeutic area: Blood and Lymphatic systems
Cancer
Vivia Biotech Personalized Medicine Test in Haematological Malignancies Biomarkers / Diagnostic Blood and Lymphatic systems
Cancer
Acute Lymphocytic Leukaemia 3CV Europe Personalized Medicine Test in Haematological Malignancies
Therapeutic area: Blood and Lymphatic systems
Cancer
Vivia Biotech Personalized Medicine Test in Haematological Malignancies Biomarkers / Diagnostic Blood and Lymphatic systems
Cancer
Chronic Lymphocytic Leukaemia 3CV Europe Personalized Medicine Test in Haematological Malignancies
Therapeutic area: Blood and Lymphatic systems
Cancer
ZeClinics ZeOncoTest Diagnostic/Imaging Cancer ZeOncoTest: a cheap, fast and reliable personalized oncological test to determine cancer treatments using zebrafish embryos as xeno-hosts for human cancer cells. 1R+D Spain ZeOncoTest
Therapeutic area: Cancer